Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Kowa/Vrije University researchers identify potent CysLT1 receptor antagonists

May 7, 1997

FDA grants SciClone orphan drug status for CPX

May 6, 1997

Sanofi claims HLE inhibitors

May 6, 1997

Nacystelyn promising alternative to NAC for lung antioxidant therapy

May 5, 1997

Dual D2/beta2 agonists disclosed by Astra

May 5, 1997

Cortech and Ono amend research agreement

May 2, 1997

Japan Tobacco discloses cytokine inhibitors

May 2, 1997

SKB describes potent, selective IL-8beta receptor antagonists

April 29, 1997

Substance P and bradykinin antagonists from Kyowa Hakko

April 25, 1997

Medtronic and Somnus to codevelop snoring and sleep apnea therapy

April 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...